Male Microchimerism at High Levels in Peripheral Blood Mononuclear Cells from Women with End Stage Renal Disease before Kidney Transplantation

Patients with end stage renal diseases (ESRD) are generally tested for donor chimerism after kidney transplantation for tolerance mechanism purposes. But, to our knowledge, no data are available on natural and/or iatrogenic microchimerism (Mc), deriving from pregnancy and/or blood transfusion, acquired prior to transplantation. In this context, we tested the prevalence of male Mc using a real time PCR assay for DYS14, a Y-chromosome specific sequence, in peripheral blood mononuclear cells (PBMC) from 55 women with ESRD, prior to their first kidney transplantation, and compared them with results from 82 healthy women. Male Mc was also quantified in 5 native kidney biopsies obtained two to four years prior to blood testing and in PBMC from 8 women collected after female kidney transplantation, several years after the initial blood testing. Women with ESRD showed statistically higher frequencies (62%) and quantities (98 genome equivalent cells per million of host cells, gEq/M) of male Mc in their PBMC than healthy women (16% and 0.3 gEq/M, p<0.00001 and p = 0.0005 respectively). Male Mc was increased in women with ESRD whether they had or not a history of male pregnancy and/or of blood transfusion. Three out of five renal biopsies obtained a few years prior to the blood test also contained Mc, but no correlation could be established between earlier Mc in a kidney and later presence in PBMC. Finally, several years after female kidney transplantation, male Mc was totally cleared from PBMC in all women tested but one. This intriguing and striking initial result of natural and iatrogenic male Mc persistence in peripheral blood from women with ESRD raises several hypotheses for the possible role of these cells in renal diseases. Further studies are needed to elucidate mechanisms of recruitment and persistence of Mc in women with ESRD

Femtosecond control of electric currents at the interfaces of metallic ferromagnetic heterostructures

The idea to utilize not only the charge but also the spin of electrons in the operation of electronic devices has led to the development of spintronics, causing a revolution in how information is stored and processed. A novel advancement would be to develop ultrafast spintronics using femtosecond laser pulses. Employing terahertz (10$^{12}$ Hz) emission spectroscopy, we demonstrate optical generation of spin-polarized electric currents at the interfaces of metallic ferromagnetic heterostructures at the femtosecond timescale. The direction of the photocurrent is controlled by the helicity of the circularly polarized light. These results open up new opportunities for realizing spintronics in the unprecedented terahertz regime and provide new insights in all-optical control of magnetism.Comment: 3 figures and 2 tables in the main tex

Beyond a phenomenological description of magnetostriction

We use ultrafast x-ray and electron diffraction to disentangle spin-lattice coupling of granular FePt in the time domain. The reduced dimensionality of single-crystalline FePt nanoparticles leads to strong coupling of magnetic order and a highly anisotropic three-dimensional lattice motion characterized by a- and b-axis expansion and c-axis contraction. The resulting increase of the FePt lattice tetragonality, the key quantity determining the energy barrier between opposite FePt magnetization orientations, persists for tens of picoseconds. These results suggest a novel approach to laser-assisted magnetic switching in future data storage applications.Comment: 12 pages, 4 figure

Breast Cancer, Sickness Absence, Income and Marital Status. A Study on Life Situation 1 Year Prior Diagnosis Compared to 3 and 5 Years after Diagnosis

Background: Improved cancer survival poses important questions about future life conditions of the survivor. We examined the possible influence of a breast cancer diagnosis on subsequent working and marital status, sickness absence and income. Materials: We conducted a matched cohort study including 4,761 women 40–59 years of age and registered with primary breast cancer in a Swedish population-based clinical register during 1993–2003, and 2,3805 women without breast cancer. Information on socioeconomic standing was obtained from a social database 1 year prior and 3 and 5 years following the diagnosis. In Conditional Poisson Regression models, risk ratios (RRs) and 95 % confidence intervals (CIs) were estimated to assess the impact of a breast cancer diagnosis. Findings: Three years after diagnosis, women who had had breast cancer more often had received sickness benefits (RR = 1.49, 95 % CI 1.40–1.58) or disability pension (RR = 1.47, 95 % CI 1.37–1.58) than had women without breast cancer. W

The spectral analysis of time series

Indeks. *** *** Bibliografi hlm. 354-358xvi, 366 hlm. ;il. ;23 cm

Steroid Hormones and Aging: Free Testosterone, Testosterone and Androstenedione in Normal Females Aged 20-87 Years

In order to investigate their pattern of change with age, free testosterone concentration (FTC), testosterone (T), androstenedione (A) and testosterone-estrogen­binding globulin (TeBG) were assayed in normal female volunteers aged 20-87. FTC was determined by equilibrium dialysis, serum A and T by radioimmunoassay and TeBG by saturation analysis. Polynomial regression and a method of smoothing grouped medians were used to obtain regression curves for each hormone by age. A declined progressively from the twenties, leveling off after age 60; FTC and T decreased slightly until age 60, tending to rise thereafter. Although TeBG showed no linear change with age, it correlated negatively with FTC in postmenopausal women. Possible relationships of androgens to female physiology and behavior, especially in the aged, are discussed

Age Differences in Serum Androgen Levels in Normal Adult Males

To help clarify their relationship to each other and to age, testosterone (T), free testosterone concentration (FTC), androstenedione (A) and sex hormone binding globulin (SHBG) were assayed in healthy, active, community-dwelling male volunteers aged 20-88 years. Standard linear and median regressions revealed mildly significant differences with age in T, whereas FTC decreased markedly, in association with an increase in SHBG. A’s pattern of age differences contrasted with that of T and FTC, exhibiting a decline from ages 20-50, tending to level off thereafter, a pattern which may reflect selection of survivors. The results for T and FTC are compared with those of other researchers; variability within studies of androgen levels in aged males may result from factors associated with subject selection, i.e., health status, physical fitness, sexual activity or other behavioral characteristics